Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-07

Clinical Trial Update: The Effect of Dapagliflozin on Platelet Function testinG Profiles in Diabetic PatiEnts. [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial investigating the effect of dapagliflozin on platelet function profiles in patients with platelet dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: The University of The West Indies | Conditions: Platelet Dysfunction | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-11-07